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Abstract
Introduction: Awareness of HIV-infection goes beyond diagnosis, and encompasses understanding, acceptance, disclosure and
initiation of the HIV-care. We aimed to characterize the HIV-positive population that underwent repeat HIV-testing without
disclosing their serostatus and the impact on estimates of the first UNAIDS 90 target.
Methods: This analysis was nested in a prospective cohort established in southern Mozambique which conducted three HIV-
testing modalities: voluntary counselling and testing (VCT), provider-initiated counselling and testing (PICT) and home-based
testing (HBT). Participants were given the opportunity to self-report their status to lay counsellors and HIV-positive diagnoses
were verified for previous enrolment in care. This study included 1955 individuals diagnosed with HIV through VCT/PICT and
11,746 participants of a HBT campaign. Those who did not report their serostatus prior to testing, and were found to have a
previous HIV-diagnosis, were defined as non-disclosures. Venue-stratified descriptive analyses were performed and factors
associated with non-disclosure were estimated through log-binomial regression.
Results: In the first round of 2500 adults randomized for HBT, 1725 were eligible for testing and 18.7% self-reported their
HIV-positivity. Of those tested with a positive result, 38.9% were found to be non-disclosures. Similar prevalence of non-disclo-
sures was found in clinical-testing modalities, 29.4% (95% CI 26.7 to 32.3) for PICT strategy and 13.0% (95% CI 10.9 to 15.3)
for VCT. Prior history of missed visits (adjusted prevalence ratio (APR) 4.2, 95% CI 2.6 to 6.8), younger age (APR 2.5, 95% CI
1.4 to 4.4) and no prior history of treatment ((APR) 1.4, 95% CI 1.0 to 2.1) were significantly associated with non-disclosure
as compared to patients who self-reported. When considering non-disclosures as people living with HIV (PLWHIV) aware of
their HIV-status, the proportion of PLWHIV aware increased from 78.3% (95% CI 74.2 to 81.6) to 86.8% (95% CI 83.4 to
89.6).
Conclusion: More than one-third of individuals testing HIV-positive did not disclose their previous positive HIV-diagnosis to
counsellors. This proportion varied according to testing modality and age. In the absence of an efficient and non-anonymous
tracking system for HIV-testers, repeat testing of non-disclosures leads to wasted resources and may distort programmatic
indicators. Developing interventions that ensure appropriate psychosocial support are needed to encourage this population to
disclose their status and optimize scarce resources.
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1 | INTRODUCTION
In 2014, UNAIDS set the ambitious global strategy of reach-
ing the 90-90-90 targets to end the HIV epidemic by 2020
[1]. This plan established that 90% of the people living with
HIV (PLWHIV) will know their HIV-status, 90% of those will
be on antiretroviral therapy (ART), and 90% of those on ART
will reach viral suppression. There has been a 29% decline in
new HIV infections in adults from 2010 to 2016 in eastern
and southern Africa, even though, this region remains the
most severely affected, where almost 19.4 million people are
currently infected with HIV [2,3]. Despite the progress,
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important challenges remain unresolved. Globally, in 2016,
30% of the 36.7 million PLWHIV did not know their HIV-sta-
tus and 47% did not receive ART [3].
Awareness of HIV infection is the first critical step in the
continuum of HIV care. However, it goes far beyond HIV sero-
logical testing and includes an understanding of the implica-
tions, acceptance of the diagnosis, willingness to disclose their
status to health providers, family members and close commu-
nity [4-6] and enrol and start in HIV care and treatment. Little
is known about the extent and causes of non-disclosure in dif-
ferent epidemic settings although it has an important impact
both at an individual and at a public health level.
Non-disclosure may lead to repeated HIV-testing and/or
repeated drop out and re-engagement in HIV care after a pos-
itive HIV-diagnosis [7]. Efforts to quantify and describe testing
inefficiencies will contribute to optimize resources to reach
the 90-90-90 objectives in high burden areas of sub-Saharan
Africa. Accurate indicators of HIV awareness, linkage and
retention in care need to take into account individuals that
are aware of their HIV-positivity but do not disclose their
serostatus to the health provider. This study sought to charac-
terize PLWHIV who fail to disclose their serostatus during
clinical and community HIV-testing campaigns in a rural dis-
trict of Southern Mozambique.
2 | METHODS
2.1 | Study area and population
The study was performed in the Manhica District, a semi-rural
area in Maputo province, southern Mozambique. Since 1996,
the Manhica Health Research Centre has run a continuous
health and demographic surveillance system (HDSS) for vital
events including births and deaths, and migrations [8] which in
2015, at the time of the study, covered a total population of
nearly 174,000 individuals [9,10]. This is a high HIV burden
setting, with an estimated community based prevalence of
39.7% among adults in 2012 [10,11]. Voluntary counselling
and testing (VCT) and provider initiated counselling and test-
ing (PICT) were the most widespread HIV-testing modalities
in the district, while home-based testing (HBT) was not rou-
tinely performed as a programmatic HIV-testing strategy. HIV-
testing and care is offered free of charge and criteria to start
ART treatment followed the WHO recommendations [12]. At
each health facility, PICT and VCT are offered and routine
patient-level HIV clinical data are recorded in an electronic
Patient Tracking System (ePTS), which allows monitoring of
the HIV population registered in the facility, the quality of
care provided as well as the retention, treatment adherence
and occurrences of opportunistic infections. HIV-testing is
anonymous in Mozambique, and the current ePTS registers
only HIV-positive patients after they have attended their first
clinical visit (further study area details on Appendix S1).
2.2 | Study procedures and definitions
The current analysis was nested in a larger prospective obser-
vational linkage cohort offering HIV-testing to adults through
VCT, PICT and HBT between May 2014 and June 2015 in the
Manhica HDSS [13] (Appendix S1). The cohort inclusion crite-
ria were adults over 18 years willing to participate, resident in
the Manhica District Hospital (MDH) catchment area, and
receiving a first HIV-positive result. Individuals at VCT and
PICT were screened for eligibility after receiving an HIV-posi-
tive result whereas HBT, patients were screened prior to test-
ing. Individuals were excluded if they were pregnant women or
co-infected with tuberculosis. HIV rapid testing was performed
following WHO/UNAIDS and national guidelines [14].
In order to be enrolled in the linkage cohort, all HIV-diag-
noses performed via VCT, PICT and HBT were verified for
the absence of a previous HIV clinical chart registered in the
ePTS available for three of district health facilities. The analy-
sis of disclosure included those patients identified as having
an HIV-diagnosis prior to the testing campaigns, either found
in the ePTS or self-reported.
One thousand nine hundred fifty-five subjects testing HIV-
positive through VCT and PICT were invited to participate in
order to reach the sample size target for the linkage cohort.
Based on the sample size calculations (Appendix S1) of the
linkage cohort study, HBT was attempted to be offered to
12,500 adults randomly selected from the all HDSS adult enu-
meration, of which 10,897 were visited at home and offered
HIV counselling and testing (HCT)The HBT campaign took
place in four field-rounds and individuals were invited to par-
ticipate in the linkage cohort prior to HCT [13]. During the
recruitment process, patients were given the opportunity to
disclose their HIV-status prior to counselling and testing when
the counsellor asked up to two times about HIV-testing his-
tory. HIV-testing was offered to all individuals who did not
disclose an HIV-positive status.
For the purposes of this study, the following definitions
were used:
• Newly HIV-diagnosed: individuals testing HIV-positive dur-
ing the campaign and not previously registered in the ePTS.
• Known HIV-positive:
• Self-reported HIV-positive: individuals disclosing previ-
ous HIV-positive diagnosis to the counsellor at any time
prior to HIV-testing. Only applicable for the HBT popula-
tion.
• Non-disclosure of HIV-positive status: individuals
accepting HIV counselling and testing without revealing
a previous HIV-diagnosis. Non-disclosure participants
were identified among VCT, PICT and HBT strategies.
• Loss to follow-up (LTFU): was defined as having the last
clinical visit performed more than 180 days before the
study visit.
2.3 | Data collection and data management
Specific questionnaires, including information on awareness of
HIV-status, history of previous HIV-testing, time since last
HIV-test and socio-demographic information were designed
for the study. Data from both clinical venues, VCT and PICT,
were collected in paper format and double-entered using the
OpenClinica platform [15]. As participants who self-reported a
previous HIV-positive diagnosis were not included in the link-
age cohort, only age and sex were recorded for those sub-
jects. Data from the HBT venue were directly collected in
electronic format in Open Data Kit software 1.4 (ODK) [16]
at the time of the visit and uploaded into a database in RED-
Cap (Research Electronic Data Capture), [17].
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As a pilot, prior to the first round of HBT (HBT-R1) a stan-
dard deterministic and probabilistic record-linkage [18] was
conducted in order to match the HDSS individuals simple ran-
domized for HBT and the Manhica hospital ePTS records for
those already enrolled in care.
In the consecutive three HBT rounds individuals identified
by that system were not visited in order to improve the effi-
ciency and yield of HBT strategy.
Ascertainment of known HIV-positive individuals was con-
ducted by confirmation of the physical hospital identification
card and/or location of individual’s name in one of the three
main district ePTS databases.
2.4 | Statistical analysis
We conducted a descriptive analysis stratified by HIV-testing
modality, assessing proportions by Pearson and Fisher’s exact
chi-square tests. For HBT analysis, data from the first round,
where adults had the opportunity to disclose their serostatus
to a study counsellor, was used for description and prevalence
whereas data from rounds 1 to 4 were used for risk-factor anal-
ysis. To assess potential risk factors associated with non-disclo-
sure to the health personnel, we estimated prevalence-ratios
(PR) through use of log-binomial regressions [19,20]. Both
unadjusted and adjusted PR (APR) were computed, and the
analysis was conducted among the HBT participants and then
among those who were enrolled in clinical care at the MDH.
Age category (18 to 24, 25 to 34, 35 to 44, >45), sex, being pre-
viously enrolled in care and LTFU were included in the model as
covariates. Confidence intervals for the binomial proportions
were calculated through the Clopper-Pearson method. Statisti-
cal analyses were performed using Stata 14.1 [21].
2.5 | Ethics
This study was approved by the Mozambican National
Bioethics Committee as well as the Institutional Review
Boards at the Hospital Clinic of Barcelona (Spain), the Manhica
Health Research Centre. It was also reviewed according to
Centres for Disease Control and Prevention (CDC) human
research protection procedures and was determined to be
research, however CDC was not engaged directly with
research participants. The purpose of the study was explained
to participants and written informed consent was obtained.
3 | RESULTS
3.1 | Study profile and baseline characteristics
During the hospital testing data collection phase, a total of
1955 people tested positive for HIV through VCT and PICT
strategies. Of these, 39.7% (776/1955) did not meet the inclu-
sion criteria for this analysis (Figure 1a). Of the remaining
1179 eligible individuals, 36.1% (426/1179) were later identi-
fied in the ePTS system as known HIV-positive (118 individuals
in VCT and 308 in PICT) and 63.9% (753/1179) were consid-
ered newly HIV-diagnosed (Figure 1a).
From the individuals randomly selected and visited for HBT-
R1, 69.0% (1725/2500) were eligible for participation; 18.7%
(322/1725) self-reported their status, and were thus consid-
ered as known HIV-positive individuals and not tested
(Figure 1b). Of those 1023 undergoing HCT, 10.6% (108/
1023) tested positive for HIV. After testing positive, 38.9% (42/
108) of the individuals were identified by the ePTS system as
known HIV-positive (Figure 1b). The record-linkage algorithm
matched an ePTS record for 42.2% (182/431) of those defined
as known HIV-positive (either self-reported or non-disclosure) in
HBT-R1.
The median age of known HIV-positive individuals from HBT,
VCT and PICT was 37.3 years (IQR 29.0 to 44.0) and signifi-
cantly higher (p < 0.001) for the HBT group 38.3 years (IQR
30.0 to 45.0) as compared to the PICT 32.5 years (IQR 26.0
to 37.0) and VCT 32.7 years (IQR 26.0 to 38.0). A signifi-
cantly higher proportion of clients in PICT were men as com-
pared to VCT and HBT (p < 0.001) (Table 1).
3.2 | Disclosure of HIV status to counsellors
From those participants included at HBT-R1, a total of 431
were defined to be known HIV-positive individuals, among which
74.7% (322/431) self-reported their HIV-status to the study
staff and. Almost 10% (42/431) underwent HCT without dis-
closing their HIV-positive status to the counsellor. An addi-
tional 15.5% (67/431) previously identified as HIV-positive by
the record-linkage algorithm were not visited (Figure 1b).
Among those testing HIV-positive in the VCT, PICT and HBT
testing campaign, the proportion of non-disclosures was high-
est in the HBT-R1 arm, reaching 38.9% (95% CI 29.7 to 48.7),
followed by the PICT at 29.4% (95% CI 26.7 to 32.3), and VCT
at 13.0% (95% CI 10.9 to 15.3) (Table 2). VCT showed a signifi-
cantly lower proportion of non-disclosures as compared to the
HBT and PICT (p < 0.001) (Table 2). The lower proportion in
HBT-all rounds as compared to HBT-R1 is due to not visiting
39.0% (849/2177) of the individuals randomized to rounds 2
to 4 with a matched record in ePTS as mentioned in methods.
3.3 | Factors associated with non-disclosure of HIV
serostatus to the health personnel
We assessed factors associated with non-disclosure among
those who had the opportunity to disclose their serostatus
over the four HBT rounds, thus excluding from the analysis
those non-disclosures in VCT and PICT. Of a total of 1328
known HIV-positive individuals, 1207 were self-reported and
121 were non-disclosures (Figure S1). In a log-binomial
regression, younger age was significantly associated with non-
disclosure of HIV-positive status (Table 3a). Individuals aged
18 to 24 years, had a 3.31 fold greater proportion (95% CI
1.91 to 5.74) of non-disclosure as compared to the reference
category of individuals over 45 years of age (Table 3a). The
association was maintained for the 25 to 34 year-old group
(adjusted prevalence ratio APR 1.77, 95% CI 1.10 to 2.87).
We then assessed the proportion of non-disclosures solely
among those 933 (70.3%) patients with a hospital identifica-
tion ePTS number and with non-missing data for covariates
included in the model (Table 3b). Again, in this population,
younger age was associated with non-disclosure (Table 3b).
Individuals aged 18 to 24 years, had a 2.47 fold greater risk
of non-disclosure (95% CI 1.38 to 4.44) compared to the ref-
erence category group. Those individuals with a history of
LTFU prior to the time of the study had a 4.24 fold greater
risk of non-disclosure (95% CI 2.64 to 6.81) than those
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without prior recorded LTFU. Furthermore, individuals with no
prior history of ART had a 1.44 fold greater risk of non-disclo-
sure (95% CI 1.01 to 2.06) than individuals enrolled in care
but on ART (Table 3b). Sex was not significantly associated
with non-disclosure of HIV serostatus.
3.4 | Impact of non-disclosure on estimates of the
first 90
We then assessed non-disclosure in the context of our popula-
tion of PLWHIV in HBT-R1 (N = 497) which included those
previously identified by the record-linkage algorithm (n = 67),
self-reported HIV-status (n = 322), non-disclosures (n = 42)
and newly HIV-diagnosed individuals (n = 66). In the absence
of a mechanism to identify non-disclosures, the apparent pro-
portion of the 497 HIV-positive individuals considered new
HIV-diagnoses would have been 21.7% (108/497) (95% CI
18.2 to 25.6) and the proportion who were aware of their
status 78.3% (389/497) (95% CI 74.4 to 81.8). However, iden-
tification of the non-disclosure population among those who
tested positive modified these proportions. Figure 2 shows
that shifting the 42/497 (8.5%, 95% CI 6.2 to 11.3) of non-
disclosures from the category of new HIV-diagnoses to the
category of known HIV-positive reduces the proportion of new
diagnoses to 13.2% (95% CI 10.4 to 16.5) and increases the
proportion who are aware of their status to 86.8% (95% CI
83.4 to 89.6) (Figure 2).
4 | DISCUSSION
Our findings show that in a semi-rural area of southern
Mozambique, the proportion of individuals who did not dis-
close previous HIV-positive status to a counsellor at the time
of HIV-testing varied according to testing venue and age.
Among those individuals testing HIV-positive in the VCT 13%
(a)
(b)
Non-disclosure
426 (36.1%)
1179 (60.3%)
NO 776 
(39.7%)
Eligible
Tested HIV positive
(VCT & PICT)  
1955
700 outside MDH catchment 
area (35.8%)
9 pregnant (0.5%)
35 Refusals (1.8%)
32 Other (1.6%)
Newly HIV diagnosed
753 (63.9%)
NO 775
(31.0%)
Newly HIV diagnosed
66 (61.1%)
903 HIV-negative (88.3%)
12 Indeterminate (1.2%)
HBT ROUND 1
2500 randomly selected HDSS adults
Eligible
1725 (69.0%)
322 Self-reported HIV+ 
(18.7%)
Tested
Non-disclosure 
42 (38.9%)
1023 (59.3%)
Tested HIV positive
108 (10.6%)
NO 380
(22.0%)
449 out of the MDH catchment area (18.0%)
14 Deaths (0.6%)
193 Missing (7.7%)
31 Pregnancies (1.2%)
21 Others (0.8%)
67 Known HIV positive (2.7%)
320 Refusals (18.6%) 
55 Self-reported negative (3.2%) 
5 other (0.3%) 
Figure 1. Study profile for (a) patients testing HIV-positive in the clinic-based testing strategies (VCT & PICT) and (b) patients testing HIV-
positive in the community strategy (HBT). Percentages are calculated over the previous step. Voluntary Counselling and Testing (VCT), Pro-
vider Initiated Counselling and Testing (PICT), Home-Based Testing (HBT), Manhica District Hospital (MDH) and Health Demographic
Surveillance System (HDSS). HBT – Refers only to the first round of HBT (n = 2500).
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underwent testing without disclosing a previous HIV-diagnosis.
This proportion was two-fold higher in PICT and three-fold
higher in HBT. In the absence of an efficient and non-anon-
ymous clinical record tracking system for HIV-testers, the
apparent proportion of the HIV-positive population who were
aware of their serostatus in the community was 78.3%. How-
ever, after record-linkage of HIV-testers with the ePTS sys-
tem, the adjusted proportion of the known HIV-positive
population rose to 86.8%, coming close to the UNAIDS target
of 90% of the HIV-positive population with an HIV-diagnosis.
Non-disclosures were more likely to be young, have dropped-
out of care and not have a history of ART.
In Sub-Saharan Africa, between 20 and 55% of the PLWHIV
has been described to be unaware of their HIV-status
[4,5,22]. Nevertheless, our results suggest that this proportion
may include individuals who are in fact aware of their HIV-sta-
tus but prefer not to disclose and to repeat the test. This may
lead to overestimation of the yield of new HIV-diagnoses and
overall HIV prevalence. Depending on the methods and back
calculations used to estimate the undiagnosed HIV population,
repeat HIV-testing might overestimate the true proportion of
PLWHIV who are still unaware of their HIV-status [23].
To ensure that 90% of PLWHIV initiate ART, treatment
delivery must be scaled-up. Expansion of ART must go beyond
treating new HIV cases and patients in follow-up without ART
criteria, to reach known HIV-positive individuals who have
dropped-out of care and are more likely to undergo repeat
testing without disclosing known HIV-positivity to the counsel-
lor. Indeed finding and re-engaging HIV-positive patients that
have been lost at any step of the care cascade and may not
disclose a prior HIV-diagnosis is equally important to ensuring
high yields of new HIV-diagnoses. Several studies have shown
a strong association between disclosure, social support and
adherence [24-27]. PLWHIV who experienced positive social
support were more likely to disclose their HIV-status and link
and retain in care, while those who perceived stigma or feared
disclosing, presented lower levels of access to care [5,26,28-
30]. Despite this, very few studies have documented the mag-
nitude of non-disclosure to health providers [31,32] and to
our knowledge, no studies have measured non-disclosure to
the lay counsellor at the moment of HIV-testing. Non-disclo-
sures may not be an isolated phenomenon. In a clinical PICT
and VCT cohort in South Africa [33], 10% of the participants
were identified as non-disclosure after re-testing whereas in a
community based trial of self-testing in Malawi, 26% of resi-
dents who self-tested were already on ART [7,34,35] The rea-
sons for non-disclosure at time of counselling may include not
believing the result, feeling that some time on treatment has
cured them or stigma among others. Furthermore studies will
shed light on the similarities and differences in non-disclosure
to a health provider versus to a partner.
The magnitude of non-disclosures can distort programmatic
indicators. At health facility level, non-disclosures could over-
estimate basic indicators, such as the number of new HIV-
diagnoses and the total number of people living with HIV as
well as underestimate the proportion of new HIV-diagnoses
Table 1. Characteristics of known HIV-positive individuals according to study HIV-testing venue
VCT PICT HBT-R1 HBT-All rounds
p
118 308 431 2177
n % n % n % n %
Age categorya 18 to 24 22 18.6% 58 18.8% 35 8.1% 214 9.8% 0.000
25 to 34 56 47.5% 146 47.4% 141 32.7% 740 34.0%
35 to 44 28 23.7% 67 21.8% 137 31.8% 650 29.9%
45 to 54 6 5.1% 24 7.8% 78 18.1% 337 15.5%
55+ 6 5.1% 12 3.9% 40 9.3% 236 10.8%
Sex Male 34 28.8% 132 42.9% 113 26.2% 566 26.0% 0.000
Female 84 71.2% 176 57.1% 318 73.8% 1611 74.0%
Serostatus Non-disclosed 118 100.0% 308 100.0% 42 9.7% 121 5.6% 0.000
Self-reported NA - NA - 322 74.7% 1207 55.4%
Determined by probabilistic
record linkage (not visited)
NA - NA - 67 15.5% 849 39.0
VCT, Voluntary Counselling and Testing; PICT, Provider Initiated Counselling and Testing; HBT, Home-Based Testing; NA, No Applicable.
aAge category in the PICT arm correspond to n = 307 participants.
Table 2. Proportion of individuals across testing strategies
(VCT, PICT and HBT) with an HIV-positive result who did not
disclose previous HIV-positivity to counsellor
Testing
venue
Total HIV-
positive
tests
HIV Non-
disclosures
Non-disclosures
% (95% CI) p
VCT 909 118 13.0% (10.9 to 15.3) <0.0001
PICT 1046 308 29.4% (26.7 to 32.3)
HBT-R1 108 42 38.9% (29.7 to 48.7)
HBT-All
rounds
490 121 24.7% (20.9 to 28.8)
VCT, Voluntary Counselling and Testing; PICT, Provider Initiated
Counselling and Testing; HBT, Home-Based Testing.
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linked to care. In Mozambique and other sub-Saharan settings,
most programmatic estimates of HIV-testing coverage and
linkage are based on comparing crude numbers of anonymous
HIV-positive tests versus number of people enrolling in care
in an unlinked manner [36,37]. Here, we document single
repeat HIV-testing in HIV-positive individuals who did not dis-
close their status to the lay counsellor. However, as long as
testing information remains anonymous, individuals may
repeat an HIV test several times without disclosing prior diag-
noses. Thus, a proportion individuals classified as new diag-
noses linked to care will actually be individuals lost over the
care cascade who should be re-engaged instead of re-tested.
Identifying repeat HIV-testers who are non-disclosers is
complicated by the generalized anonymity of the HIV-diagno-
sis in Mozambique [38]. With the increasing benefits of ART
and challenges in linking new HIV-diagnoses to care, WHO
has revised its surveillance testing guidelines to move away
from anonymous testing and encourage confidential linked
HIV testing [14]. In our study, under informed consent, HIV-
testing was not anonymous and thus allowed tracking these
patients. Another important health system related obstacle is
the reliance on paper charts when patients enrol in care. Digi-
tal entry of the clinical information in the ePTS is secondary
to the clinical visit, where the information is recorded directly
on the paper chart. Mckay et al. described the phenomenon of
“medical multiplicity” in Maputo health facilities where one
individual may have multiple charts [39]. In addition, each
health facility has their own clinical ePTS database, which
complicates tracking silent transfers and migrants from one
health post to another. Mechanisms such as the confirmation
of the identity of individuals testing HIV-positive prior to
enrolment or the removal of anonymity of the HIV-diagnosis
implemented in our study allowed us to reduce the problem
of ‘medical multiplicity’.
Table 3. Factors associated with prevalence of non-disclosure of HIV status in the HBT population in (a) the entire HBT population
(n = 1328) or (b) those who were enrolled in clinical care at the MDH (n = 933)
Prevalence
% (n/N) PR 95% CI p APR 95% CI p
a)
Age category 18 to 24 20.41 (20/98) 3.69 2.11 to 6.45 <0.001 3.31 1.91 to 5.74 <0.001
25 to 34 11.14 (45/404) 2.01 1.24 to 3.27 0.005 1.77 1.10 to 2.87 0.019
35 to 44 8.05 (33/410) 1.46 0.87 to 2.44 0.153 1.31 0.78 to 2.18 0.302
>45 5.53 (23/416) 1.00 - - 1.00 - -
Sex Male 10.6 (37/349) 1.24 0.86 to 1.78 0.258 1.27 0.88 to 1.82 0.196
Female 8.58 (84/979) 1.00 - - 1.00 - -
b)
Age category 18 to 24 25.71 (18/70) 3.71 2.04 to 6.75 <0.001 2.47 1.38 to 4.44 0.002
25 to 34 13.64 (42/308) 1.97 1.16 to 3.34 0.012 1.49 0.89 to 2.49 0.131
35 to 44 9.49 (28/295) 1.37 0.78 to 2.42 0.276 1.07 0.61 to 1.86 0.817
>45 6.92 (18/260) 1.00 - - 1.00 - -
Sex Male 13.01 (32/246) 1.21 0.82 to 1.78 0.341 1.18 0.82 to 1.70 0.381
Female 10.77 (74/687) 1.00 - - 1.00 - -
History of ART prior to
testing campaign
No 22.12 (50/226) 2.79 1.97 to 3.97 <0.001 1.44 1.01 to 2.06 0.045
Yes 7.92 (56/707) 1.00 - - 1.00 - -
History of LTFU prior to
testing campaign
Yes 21.43 (84/392) 5.27 3.36 to 8.27 <0.001 4.24 2.64 to 6.81 <0.001
No 4.07 (22/541) 1.00 - - 1.00 - -
PR, Prevalence Ratio; APR, Adjusted Prevalence Ratio; ART, Anti-retroviral Therapy.
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Figure 2. Impact of linking HIV testing results to patient registries
on proportion of HIV-infected individuals that know their status.
(n = 497)
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In this study, we did not conduct qualitative analyses to
understand the reasons for non-disclosure to the counsellor
or to ascertain non-disclosure to family members. However,
the need for understanding the main reasons for non-disclo-
sure has increased in recent years as a greater proportion
of the population is tested for HIV. Identifying barriers
could reduce the magnitude of the problem and potentially
improve adherence to ART and care due to the close rela-
tionship between disclosure and adherence [5,26,28-30]. The
main reasons for non-disclosure at various levels (partners,
family, friends, healthcare providers or even employers) are
fear of discrimination or rejection [40], stigma [27,30,41-43]
or previous negative experiences disclosing to a confident
[28]. In Mozambique, results from a national stigma survey
have shown that more than 50% of people interviewed had
experienced some form of discrimination in the previous
year and less than 40% knew that they had rights as HIV
patients [27,44]. Only half of the population of the survey
had disclosed their status to their sexual partner or family
[44].
Interventions that reduce stigma and empower PLWHIV will
improve individual and social context outcomes. These inter-
ventions should be aimed at increasing sensitization, retention
in care and de-stigmatization of HIV at both individual and
public health level [27,30].
The main limitation of this study is related to the method of
identification of the non-disclosure population based on the
ePTS, which only records individuals with a clinical visit rather
than all those diagnosed and is independent by health facility.
Thus, we were not able to include individuals who knew their
HIV-status but had not reached the point of a clinical visit or
individuals that were enrolled in other health facilities. In addi-
tion, for HBT-all rounds, our estimate of non-disclosure is con-
servative because individuals that were identified as known
HIV-positive through the record -linkage algorithm were not
provided with the opportunity to disclose their HIV condition.
This is likely to lead to underestimation of the prevalence of
non-disclosure. With quality systems that allow the identifica-
tion of previously diagnosed individuals, we will have the
capacity to accurately measure the proportion of people still
unaware of their HIV condition, after implementing all the
strategies proposed to reach the first 90 goal.
5 | CONCLUSIONS
In high HIV burden settings such as Southern Mozambique,
close to 40% of people who tested positive within different
HCT strategies had a prior HIV-positive diagnosis. Repeat
HIV-testing of previously diagnosed individuals may con-
tribute to medical multiplicity, wasting of scarce resources
and distortion of programmatic indicators. In the absence of
an efficient and non-anonymous tracking system for HIV-tes-
ters, repeat testing of non-disclosing PLWHIV leads to mis-
classification between linkage and re-engagement in care and
can potentially lead to an underestimation of the first
UNAIDS 90 objective. Since HIV-status disclosure is believed
to affect overall physical and mental health including disease
transmission and the quality of relationships, understanding
disclosure behaviour can impact many aspects of wellbeing
of PLWHIV.
These findings point to a need, not only to link new HIV-
diagnoses to care but also to address the gap of re-engage-
ment at every step of the cascade in order to avoid extensive
repeat HIV-testing. Youths have become a target group for
intensification of HIV-testing. However, attention must be
given to strategies of re-engagement in care without repeating
HCT. Intensifying the importance of disclosure and re-engage-
ment during counselling as well as ensuring appropriate psy-
chosocial support are necessary to encourage PLWHIV to
disclose their status.
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